Add BrightSurf on Google Email

Tokyo Medical and Dental University


Blue is the clue to evaluating diabetic retinopathy

Researchers from Tokyo Medical and Dental University have developed a non-invasive imaging technique using blue light to identify areas affected by diabetic retinopathy. The study found that blue images obtained through multicolor widefield scanning laser ophthalmoscopy (SLO) can reveal hyporeflective areas indicative of damage associa...

SourceTokyo Medical and Dental University·JournalAsia-Pacific Journal of Ophthalmology·DateOct 28, 2021

Food for thought: Eating soft foods may alter the brain's control of chewing

Researchers at Tokyo Medical and Dental University found that a diet of soft or regular food affects muscle control and electrical activity of the jaw when stimulated, influencing the regulation of chewing. This study suggests that increasing chewing difficulty may alter brain control, with potential benefits for monitoring and improvi...

SourceTokyo Medical and Dental University·JournalScientific Reports·DateJun 9, 2021

Horizontal transmission can cause severe and persistent eye inflammation

A new study by Tokyo Medical and Dental University clinicians reveals that horizontal transmission is responsible for HTLV-1 uveitis, a severe eye inflammation. The patient was treated with corticosteroids, showing promise in managing the condition, but highlighting the need to consider infection route in diagnosis and treatment.

SourceTokyo Medical and Dental University·JournalThe Lancet Infectious Diseases·DateApr 27, 2021

An antibody-drug combo to combat cancer

Researchers at Tokyo Medical and Dental University developed an antibody-drug conjugate that selectively targets human monocyte progenitors to combat chronic myelomonocytic leukemia (CMML). This strategy effectively blocks malignant cell proliferation with minimal collateral damage to other cell lineages.

SourceTokyo Medical and Dental University·JournalFrontiers in Immunology·DateApr 16, 2021

HIV has been had

Researchers at Tokyo Medical and Dental University develop novel molecules that mimic CD4 proteins, preventing HIV particles from entering immune cells. These compounds show promise in reducing side effects while increasing effectiveness in stopping viral proliferation.

SourceTokyo Medical and Dental University·JournalJournal of Medicinal Chemistry·DateApr 15, 2021

Lighting up bone repair

A team at Tokyo Medical and Dental University developed a material that aids in bone healing, allows for clear assessment of bone damage and clarifies probable patient outcomes. The material incorporates a fluorescent molecule, enabling real-time visual analysis and predictions of therapeutic outcomes.

SourceTokyo Medical and Dental University·JournalCommunications Chemistry·DateMar 24, 2021